On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Q&A With Daniel Ouellette From Henry Ford Hospital: Benefits Seen In Raising Smoking Age To 21
With the federal government leaving it to state and local entities to determine the age at which tobacco products can be purchased, an effort is underway to advance the age limit three years to 21.
AGA Supports Scientists' Call for National Movement on The Microbiome
The American Gastroenterological Association (AGA) recently announced its support for the interdisciplinary Unified Microbiome Initiative, which is focused on developing a fuller understanding of the microbiome.
Study: Compound Cures Hepatitis C in Less than 3 Weeks
Results from a small study conducted in China suggest that a novel combination treatment could cut by 75% the treatment time of current HCV medications, which themselves cut in half the time for successful treatment only a decade ago.
Treating Substance Abuse and Addiction in HIV Patients
November 3rd 2015A program that integrated addiction treatment into primary care for patients with, or at risk for, HIV appears to successfully engage and treat patients with substance dependence. Developed by researchers at Boston Medical Center, the program was shown to reduce substance dependence and encourage engagement in treatment.
COPD: Comorbidities in a High-Risk State
In Kentucky, chronic obstructive pulmonary disease (COPD) and multiple comorbidities are major public health issues, and there is variation in the occurrence of both COPD and the various comorbidities depending on both gender and where in the state people live. A research team looked at the factors contributing to both.
One in Five Pediatricians Say Goodbye to Families Who Refuse Vaccines
November 3rd 2015Vaccination is a hot topic of controversy, to say the very least. But if patients refuse to get vaccinated against preventable diseases such as measles and mumps, some doctors will go as far as to dismiss the families from their practices.
Multidisciplinary Feedback Improves Surgeons' Performance
November 3rd 2015Certain healthcare provider behaviors can threaten team performance and patient safety. As task complexity increases, so do the team's interdisciplinary responsibilities. Medical organizations that take steps to identify troublesome behaviors can help employees correct the problem, thereby fostering teamwork and a culture of safety.
Simultaneous Bariatric Surgery and Hiatal Hernia Repair Appears Safe
November 3rd 2015Some experts contend that hiatal hernia-related symptoms improve after weight-loss surgery, making repair of the hiatus unnecessary. Yet, simultaneous repair during bariatric surgery may be more efficient than undergoing separate procedures. A study published in the journal Surgery suggests repair of hiatal hernia during bariatric surgery appears safe and feasible.
Good Results with Early Resective Surgery for Epilepsy
November 3rd 2015Surgeons are more likely than ever to consider resective procedures in infants and young children who have refractory seizure disorders. Many reports describe good outcomes in infants and young children undergoing resective surgery, but longitudinal data have been published only rarely.
Using EMRs to Analyze Diabetes Subtypes
There are many varieties of type 2 diabetes, a new genotype analysis shows. Tracking these genotype variations in common diseases is possible using data from electronic medical records (EMRs), according to researchers at the Icahn School of Medicine at Mount Sinai in New York City.
Predicting Spinal Surgery Patient Satisfaction
Researchers recently studied a cohort of patients who had undergone surgery for back pain to determine if they could identify patient-related factors or patient-reported outcomes could accurately predict dissatisfaction after spinal surgery.
Second Study Confirms Safety and Efficacy of Interferon-free HCV Combination
Study results show that the interferon-free regimen of simeprevir plus sofosbuvir achieves high rates of sustained virologic response and has a strong safety profile for patients with hepatitis C.